Table 5. Association of medications and mortality.
| Outcome | Hazard ratio | P value |
|---|---|---|
| Overall death | ||
| Statin | 0.696 (0.559-0.867) | 0.001 |
| Beta-blocker | 0.731 (0.624-0.857) | <0.001 |
| Ace-inhibitor | 0.923 (0.769-1.109) | 0.39 |
| Statin* | 0.744 (0.59-0.93) | 0.01 |
| + Beta-blocker# | 0.753 (0.64-0.88) | 0.001 |
| + Ace-inhibitorΔ | 0.936 (0.78-1.13) | 0.482 |
| 1 year death | ||
| Statin | 0.424 (0.264-0.681) | <0.001 |
| Beta-blocker | 0.438 (0.321-0.597) | <0.001 |
| Ace-inhibitor | 0.669 (0.467-0.960) | 0.023 |
| Statin* | 0.531 (0.328-0.860) | 0.01 |
| + Beta-blocker# | 0.460 (0.336-0.629) | <0.001 |
| + Ace-inhibitorΔ | 0.683 (0.475-0.983) | 0.04 |
*, combined use of statin, beta-blocker and ace-inhibitor; #, combined use of statin and beta-blocker; Δ, combined use of statin and ace-inhibitor.